Use of Contezolid for the Treatment of Refractory Infective Endocarditis in a Patient with Chronic Renal Failure: Case Report

Infective endocarditis (IE) caused by methicillin-resistant Staphylococcus aureus (MRSA) is usually life threatening and difficult to treat. Contezolid is a newly approved oxazolidinone antimicrobial agent showing potent activity against MRSA. We successfully treated a case of refractory IE caused b...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Sheng, Zhang, Wei, Zhang, Linfei, Zhang, Jing, Li, Jinghang, Si, Linjie, Ding, Yi, Li, Mingke, Song, Yuanyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276592/
https://www.ncbi.nlm.nih.gov/pubmed/37333679
http://dx.doi.org/10.2147/IDR.S413452

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10276592/
https://www.ncbi.nlm.nih.gov/pubmed/37333679
http://dx.doi.org/10.2147/IDR.S413452

Ejemplares similares